Skip to main content
. 2022 Mar 10;30(1):16–23. doi: 10.1097/LBR.0000000000000839

TABLE 1.

Demographics, Location and Size of Nodule, Pathologic Diagnosis, Distance From Pleura, Target Correction, Sedation Types and Complications

Demographics N (%)
Total patients enrolled 72 (—)
Total pulmonary nodules 78 (—)
Sex
 Male 48/72 (66.7)
 Female 24/72 (33.3)
Age
 Range 37-96
 Median 69
Location of nodule
 Right upper lobe 32/78 (40.1)
 Right middle lobe 8/78 (10.2)
 Right lower lobe 9/78 (11.5)
 Left upper lobe 22/78 (28.2)
 Left lower lobe 7/78 (8.9)
Pathologic diagnosis
 Malignant 61/78 (78.2)
 Nonmalignant 7/78 (8.9)
 Nondiagnostic 10/78 (12.8)
Sedation type
 General anesthesia 16/72 (22.2)
 Moderate sedation 56/72 (77.8)
Complications
 Pneumothorax 2/78 (2.6)
Size of nodule, cm
 Overall median size 2
 Range 0.8-4
 <1 1/78 (1.3)
 1-1.9 22/78 (28.2)
 2-3 54/78 (69.2)
 >3 1/78 (1.2)
Distance from the pleura, mm
 Overall distance (median) 1
 Range 1-15
 1 45/78 (58)
 2 11/78 (14)
 3 10/78 (13)
 4 6/78 (8)
 5 5/78 (5)
 >5 1/78 (1)
Target correction, mm
 Average 15.4
 Minimum-maximum 0.4-29.8
Suspected clinical stage
 Stage I 25/72 (34.7)
 Stage II 17/72 (23.6)
 Stage III 8/72 (11.1)
 Stage IV 22/72 (30.5)

Percentages are listed out of 78 total number of nodules and 72 total patients. Suspected clinical stage I to IV before bronchoscopy (based of CT scan review and 8th edition of TNM staging of lung cancer).

CT indicates computed tomography; N, number of pulmonary nodules or patients; TNM, primary tumor, regional lymph nodes, distant metastasis.